Keizo Koya Insider Trading $SNTA MADRIGAL PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Keizo Koya.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keizo Koya. Keizo Koya is Sr. VP, Drug Development in SYNTA PHARMACEUTICALS CORP ($SNTA).
Keizo Koya in MADRIGAL PHARMACEUTICALS, INC.
Trading Symbol: SNTAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keizo Koya: Sr. VP, Drug Development
Holdings: 12,999 shares
Latest Transaction: Mar 08 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Keizo Koya in MADRIGAL PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 08 2012 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Option Exercise | A | 4.22 | 63,036 | 266,012 | 63,036 | |
Mar 05 2012 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Sell | S | 4.70 | 6,844 | 32,187 | 12,999 | 19.8 K to 13 K (-34.49 %) |
Apr 26 2011 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Sell | S | 6.00 | 10,000 | 60,000 | 19,843 | 29.8 K to 19.8 K (-33.51 %) |
Apr 26 2011 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Sell | S | 5.60 | 10,000 | 56,000 | 29,843 | 39.8 K to 29.8 K (-25.10 %) |
Mar 03 2011 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Option Exercise | A | 5.26 | 58,200 | 306,132 | 58,200 | |
Mar 03 2011 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Grant | A | 0.00 | 6,844 | 0 | 39,843 | 33 K to 39.8 K (+20.74 %) |
Mar 03 2011 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Sell | S | 5.23 | 18,270 | 95,552 | 32,999 | 51.3 K to 33 K (-35.64 %) |
Mar 03 2010 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Option Exercise | A | 4.02 | 76,362 | 306,975 | 76,362 | |
Mar 03 2010 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Grant | A | 0.00 | 8,224 | 0 | 51,269 | 43 K to 51.3 K (+19.11 %) |
Aug 26 2009 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Buy | P | 2.84 | 10,000 | 28,434 | 43,045 | 33 K to 43 K (+30.26 %) |
Apr 14 2009 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Option Exercise | A | 2.49 | 44,616 | 111,094 | 44,616 | |
Feb 29 2008 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Option Exercise | A | 8.82 | 42,120 | 371,498 | 42,120 | |
Feb 28 2007 | SNTA | SYNTA PHARMACEUTIC ... | Koya Keizo | Sr. VP, Drug Develo ... | Option Exercise | A | 8.75 | 26,000 | 227,500 | 26,000 |
Page: 1